Amy Comstock Rick - PARKINSONS

By far, the greatest challenge facing the Parkinson’s community today is the lack of disease modifying therapies to slow or stop the progression of the disease. Parkinson’s disease is one of the most complicated diseases we know of. No two people with Parkinson’s have the same symptoms, and there is no one-size-fits-all approach to treating the disease. People affected are often forced to stop working and manage their disease full time. If Parkinson’s itself isn’t disrupting enough, often the medications used to treat the disease cause a host of side effects that impact the quality of life and sometimes stop being effective all together. People with Parkinson’s and their caregivers will tell you that this disease simply takes over every aspect of their lives. So how do the up to 1.5 million Americans living with Parkinson’s find hope? Through the progress researchers make toward finding ways to stop or slow the progression of Parkinson’s. Whether its movement toward understanding the genetics of Parkinson’s, the environmental effects, such as traumatic brain injury, or the quest for a biomarker, we will not make strides toward a cure without continued support of federally funded research at the National Institutes of Health (NIH) and the Department of Defense (DoD). One of the most promising developments to come out of the research world recently is a new set of research priorities established by National Institute for Neurological Disorders and Stroke (NIND...
Source: PHRMA - Category: Pharmaceuticals Authors: Source Type: news